KTD-092
Product Specifications
Target
DYRK
Related Pathways
Cell Cycle/Checkpoint, Tyrosine Kinase/Adaptors
Bioactivity
KTD-092, a DYRK1A inhibitor, exhibits an IC50 of 22 nM against human DYRK1A. It is applicable in research related to Down syndrome (DS), Alzheimer's disease (AD), autism spectrum disorder (ASD), diabetes, and other neurodegenerative diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134101-PE 100 µL
SUPT4H1 (Transcription Elongation Factor SPT4, hSPT4, DRB Sensitivity-inducing Factor 14kD Subunit, DSIF p14, DRB Sensitivity-inducing Factor Small Subunit, DSIF Small Subunit, SPT4H, SUPT4H) (PE)
Sign In for Pricing
View Details 
LS026271-100ug 100 µg
Emi1 (FBXO5) (NM_012177) Human Over-expression Lysate
Sign In for Pricing
View Details 